RBR-2ggx7sm尚未招募未知
COVID-19-vaccinated plasma for treatment of the infection by SARS-CoV-2: a Multicenter,Randomized, Open-Label, Parallel-Group Trial
Ministério da Ciência, Tecnologia e Inovações0 个研究点开始时间: 2022年1月11日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Intervention
入排标准
- 年龄范围
- 18Y 至 0（—）
入选标准
- •Age = 18 years with or without comorbidity; COVID-19 mild (WHO clinical progression scale = 2); Symptoms duration less than 72 hours; Laboratory confirmation of COVID-19, by detecting the viral antigen in respiratory secretions, collected by nasal swab (PanbioTM COVID-19 Ag, Abbott®); Signature, by the patient or a legal representative, of the informed consent form
排除标准
- •Pregnant women; Patients in palliative care; Refusal to sign the TCLEP; Patients immunized with two doses of the immunizers, with the exception of individuals over 80 years of age who have been immunized with Coronavac vaccine for more than 6 months; Patients with suspected reinfection; Allergic reactions prior to plasma transfusion
研究者
相似试验
招募中
3 期
Treatment of Covid-19 patients with convalescent plasmaCOVID-19 disease.IRCT20200525047562N1High Educational and Research Institute of Transfusion Medicine100
招募中
不适用
se of Convalescent Plasma in the treatment of COVID-19IRCT20200414047072N1Hilton Pharma Pvt. Ltd.357
终止
2 期
Transfusion of Convalescent Plasma for the Early Treatment of Patients With COVID-19COVIDSARS-CoV 2NCT04393727Azienda Ospedaliero, Universitaria Pisana1
进行中（未招募）
1 期
Safety and tolerability evaluation of PE in patients with Post-Acute Covid-19 Syndrome (PCC) compared to sham plasma exchange (placebo).Post-Acute-Covid-19 SyndromeMedDRA version: 24.0Level: PTClassification code 10085503Term: Post-acute COVID-19 syndromeSystem Organ Class: 10021881 - Infections and infestationsEUCTR2022-000641-33-ESFundacio´ FLS de Lluita contra la Sida, les Malalties Infeccioses i la Promocio´ de la Salut i La Cie`ncia50
已完成
不适用
Effect of COVID 19 survivors plasma in COVID 19 patients with ARDSIRCT20200409047007N1Mashhad University of Medical Sciences64